Cell death and longevity: Implications of Fas-mediated apoptosis in T-cell senescence

Immunological Reviews

Volumn 160, Issue , 1997, Pages 19-30

  Mountz, John D ^a,b,c   Wu, Jianguo ^a   Zhou, Tong ^a   Hsu, Hui Chen ^a  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD45 ANTIGEN; CELL DNA; FAS ANTIGEN; PHOSPHOTRANSFERASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; SERUM AMYLOID A;

ACUTE PHASE RESPONSE; AGING; APOPTOSIS; CELL CYCLE; CELL DEATH; CELL LINE; DNA DAMAGE; GLOMERULUS; HUMAN; IMMUNE RESPONSE; LIFESPAN; MEMORY CELL; MONONUCLEAR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SENESCENCE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENE;

ACUTE-PHASE REACTION; AMYLOIDOSIS; ANIMALS; ANTIGENS, CD2; ANTIGENS, CD95; APOPTOSIS; CELL AGING; DNA DAMAGE; FORECASTING; HUMANS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES;

EID: 0031463643     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1997.tb01024.x     Document Type: Review

References (68)

1. Knight JA. The process and theories of aging. Ann Clin Lab Sci 1995;25:1-12.
2. Miller RA. The aging immune system: primer and prospectus. Science 1996;273:70-74.
3. Thoman ML, Ernst DN, Hobbs MV, Weigle WO. T-cell differentiation and functional maturation in aging mice. Adv Exp Med Biol 1993;330:93-106.
4. Raff MC. Social controls on cell survival and cell death. Nature 1992;356:397-399.
5. Sager R. Senescence as a mode of tumor suppression. Environ Health Perspect 1991;93:59-62.
6. Lewis SE, Holliday R. Mistranslation and aging in Neurospora. Nature 1970;228:877-880.
7. Sohal RS, Ku H, Agarwal MJ, Forster MJ, Lai H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech Aging Dev 1994;74:121-133.
8. Kruk PA, Rampino NJ, Bohr VA. DNA damage and repair in telomeres. Relation to aging. Proc Nad Acad Sci USA 1995;92:258-262.
9. Zhou T, Edwards III CK, Mountz JD. Prevention of age-related T cell apoptosis defect in CD2-fas transgenic mice. J Exp Med 1995;182:129-137.
10. Herndon FJ, Hsu H-C, Mountz JD. Increased apoptosis of CD45RO- T cells with aging. Mech Age Dev 1997;94:123-134.
11. Chrest FJ, Buchholz MA, Kim YH, Kwon T-K, Nordin AA. Anti-CD3-induced apoptosis in T-cells from young and old mice. Cytometry 1995;20:33-42.
12. Collins MK, Perkins GR, Rodriguez-Tarduchy G, Nieto MA, Lopez-Rivas A. Growth factors as survival factors: regulation of apoptosis. Bioessays 1994:16:133-138.
13. Purdie CA, et al. Tumor incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 1994;9:603-609.
14. Reed JC, et al. Differential expression of bcl-2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res 1991;51:6529-6538.
15. Cohen PL, Eisenberg RA. The lpr and gld genes in systemic autoimmunity: life and death in the fas lane. Immunol Today 1992;13:427-428.
16. Ju S-T, et al. Fas (CD95)/FasL interactions required for programmed cell death T cell activation. Nature 1995;373:444-448.
17. Brunner T, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995;373:441-443.
18. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995;373:438-440.
19. Engwerda CR, Handwerger BS, Fox BS. Aged T cells are hyporesponsive to co-stimulation mediated by CD28. J Immunol 1994;152:3740-3747.
20. Phelouzat MA, Arbogast A, Laforge T, Quadri RA, Proust JJ. Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence. Mech Aging Dev 1996;88:25-38.
21. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989;169:1747-1756.
22. Rathmell JC, et al. CD95(Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+ T cells. Nature 1995;376:181-183.
23. 2+-independent T cell-mediated cytotoxicity. J Exp Med 1993;177:195-200.
24. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
25. Takahashi T, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994;76:969-976.
26. Andrews BS, et al. Spontaneous murine lupus-like syndrome: clinical and immunopathological manifestations in several strains. J Exp Med 1978;148:1198-1207.
27. Wu J, Zhou T, Zhang J, He J, Gause WC, Mountz JD. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc Natl Acad Sci USA 1994;91:2344-2348.
28. Greaves DR, Wilson FD, Lang G, Kioussie D. Human CD2 3′-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice. Cell 1989;56:979-986.
29. Crass BA, Bergdoll MS. Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndromes. J Clin Microbiol 1986;23:1138-1139.
30. Hsu H-C, Zhou T, Yang PA, Herrera GA, Mountz JD. Increased acute-phase response and renal amyloidosis of aged CD2-fus transgenic mice. J Immunol 1997;158:5988-5996.
31. McNiff PA, Stewart C, Sullivan J, Showell HJ, Gabel CA. Synovial fluid from rheumatoid arthritis patients contains sufficient levels of IL-1β and IL-6 to promote production of serum amyloid A by Hep3B cells. Cytokine 1995;7:209-219.
32. Cohen AS, Shirahama T, Sipe JD, Skinner M. Amyloid proteins, precursors, mediator, and enhancer. Lab Invest 1983;48:1-4.
33. Glenner GG. Amyloid deposits and amyloidosis. N Engl J Med 1983;302:1283-1292.
34. Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 1993;102:131-146.
35. Kisilevsky R. Serum amyloid A (SAA), a protein without a function: some suggestions with reference to cholesterol metabolism. Med Hypotheses 1991;35:337-341.
36. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81-88.
37. Renno T, Hahne M, MacDonald R. Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo. J Exp Med 1995;181:2283-2287.
38. Huang L, Soldevila G, Lecker M, Flavell R, Crispe IN. The liver eliminates T cell undergoing antigen-triggered apoptosis in vivo. Immunity 1994;1:741-749.
39. Papaconstantinou J. Unifying model of the programmed (intrinsic) and stochastic (extrinsic) theories of aging. The stress response genes, signal transduction-redox pathways and aging. Ann N Y Acad Sci 1994;719:195-218.
40. Noda A, Ning Y, Venable SF, Pereira-Smith OL, Smith JR. Cloning of senescent cell derived inhibitors of DNA synthesis using an expression system. Exp Cell Res 1994;211:90-98.
41. Johnson M, et al. Evidence for a p53-dependent pathway for upregulation of Sdi1/CIP1/WAF1/p21 RNA in human cells. Mol Carcinogenesis 1994:11:59-64.
42. El-Deiry WS, et al. Waf1/Cip1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-1174.
43. Xiong Y, Hannon GY, Zhang H, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993;336:701-704.
44. Dulié V, et al. p53-dependent inhibition of cyclin-dependent kinase activities in human during radiation-induced G1 arrest. Cell 1994;76;1013-1023.
45. Sancar A. DNA repair in humans. Annu Rev Genet 1993;29:69-105.
46. Finnie NJ, Gottlieb TM, Blunt T, Jeggo P, Jackson SP. DNA-PK activity is absent in xrs-6 cells: implications for site-specific recombination and DNA double-strand break repair. Proc Natl Acad Sci USA 1995;92:320-324.
47. Wang ZQ, et al. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 1995;9:509-520.
48. de Murcia G, Menissier de Murcia J. Poly (ADP-ribose) polymerase: a molecular sensor. Trends Biochem Sci 1994;19:172-176.
49. Troelstra C, van-Gool A, de Wit J, Vermeulen W, Bootsma D, Hoeijmakers JHJ. ERCC6, a member of a subfamily of putative helicase, is involved in Cockayne's syndrome and preferential repair of active genes. Cell 1992;71:939-953.
50. Li R, Waga S, Hannon GJ, Beach D, Stillman B. Differential effects by the p21 inhibitor on PCNA-dependent DNA replication and repair. Nature 1994;371:534-537.
51. Casciola-Rosen LA, Anhalt GJ, Rosen A. DNA-dependent protein kinase is one of subsets of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995;182:1625-1634.
52. McConnell KR, Dynan WS, Hardin JA. The DNA-dependent protein kinase (p460) is cleaved during Fas-mediated apoptosis in Jurkat cells. J Immunol 1997;158:2083-2089.
53. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly(ADP-ribose)polymerase by a proteinase with properties like ICE. Nature 1994;346:346-347.
54. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614-636.
55. Yu C-E, et al. Positional cloning of the Werners syndrome gene. Science 1996;272:258-261.
56. Savitsky K, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995;268:1749-1753.
57. Ellis NA, et al. The Bloom's syndrome gene product is a homologous to RecQ helicases. Cell 1995;83:655-666.
58. Weirich-Schwaiger H, Weirich HG, Gruber B, Schweiger M, Hirsch-Kauffmann M. Correlation between senescence and DNA repair in cells from young and old individuals and in premature aging syndromes. Mutation Res 1994;316:37-48.
59. Yu C-E, et al. Disequilibrium and hapoltype studies of chromosome 8p11.1-21.1 markers and Werner syndrome. Am J Hum Genet 1994;55:356-364.
60. Thweatt R, Murano S, Fleischmann RD, Goldstein S. Isolation and characterization of gene sequences overexpressed in Werner syndrome fibroblasts during replicative senescence. Exp Gerontol 1992;27:433-440.
61. Oshima J, Campisi J, Tannock TC, Martin GM. Regulation of c-fos expression in senescence Werner syndrome fibroblasts differs from that observed in fibroblasts from normal donors. J Cell Physiol 1995;162:277-283.
62. Murano S, et al. Diverse gene sequences are overexpressed in Werner syndrome fibroblasts undergoing premature replicative senescence. Mol Cell Biol 1991;11:3905-3914.
63. Reap EA, Roof K, Maynor K, Borrero M, Booker J, Cohen PL. Radiation and stress-induced apoptosis: a role of Fas/FasL interactions. Proc Natl Acad Sci USA 1997;94:5750-5755.
64. Leverkus M, Yaar M, Gilchrest BA. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp Cell Res 1997;232:255-262.
65. Oguri-Hyakumachi N, Takahashi S, Nakagawa T, Kikuchi K. Selective depletion of cyclin- dependent kinases is associated with Fas-mediated apoptosis in human leukemia T cell lines. Int J Immunopharmacol 1995;17:913-921.
66. Casiano CA, Martin SJ, Green DR, Tan EM. Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)-mediated T cell apoptosis. J Exp Med 1996;184:765-770.
67. Kerr B, Ashcroft GS, Scott D, Horam MA, Ferguson MW, Donnai D. Rothmund-Thomson syndrome: two case reports show heterogenous cutaneous abnormalities, an association with genetically programmed ageing changes, and increased chromosomal radiosensitivity. J Med Genet 1996;33:928-934.
68. Prache-de-Carrere B, et al. Rothmund-Thomson syndrome with reduced DNA repair capacity. Ann Dermatol Venereol 1996;123:395-397.